Unknown

Dataset Information

0

Lethality of PAK3 and SGK2 shRNAs to human papillomavirus positive cervical cancer cells is independent of PAK3 and SGK2 knockdown.


ABSTRACT: The p21-activated kinase 3 (PAK3) and the serum and glucocorticoid-induced kinase 2 (SGK2) have been previously proposed as essential kinases for human papillomavirus positive (HPV+) cervical cancer cell survival. This was established using a shRNA knockdown approach. To validate PAK3 and SGK2 as potential targets for HPV+ cervical cancer therapy, the relationship between shRNA-induced phenotypes in HPV+ cervical cancer cells and PAK3 or SGK2 knockdown was carefully examined. We observed that the phenotypes of HPV+ cervical cancer cells induced by various PAK3 and SGK2 shRNAs could not be rescued by complement expression of respective cDNA constructs. A knockdown-deficient PAK3 shRNA with a single mismatch was sufficient to inhibit HeLa cell growth to a similar extent as wild-type PAK3 shRNA. The HPV+ cervical cancer cells were also susceptible to several non-human target shRNAs. The discrepancy between PAK3 and SGK2 shRNA-induced apoptosis and gene expression knockdown, as well as cell death stimulation, suggested that these shRNAs killed HeLa cells through different pathways that may not be target-specific. These data demonstrated that HPV+ cervical cancer cell death was not associated with RNAi-induced PAK3 and SGK2 knockdown but likely through off-target effects.

SUBMITTER: Zhou N 

PROVIDER: S-EPMC4304782 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lethality of PAK3 and SGK2 shRNAs to human papillomavirus positive cervical cancer cells is independent of PAK3 and SGK2 knockdown.

Zhou Nannan N   Ding Bo B   Agler Michele M   Cockett Mark M   McPhee Fiona F  

PloS one 20150123 1


The p21-activated kinase 3 (PAK3) and the serum and glucocorticoid-induced kinase 2 (SGK2) have been previously proposed as essential kinases for human papillomavirus positive (HPV+) cervical cancer cell survival. This was established using a shRNA knockdown approach. To validate PAK3 and SGK2 as potential targets for HPV+ cervical cancer therapy, the relationship between shRNA-induced phenotypes in HPV+ cervical cancer cells and PAK3 or SGK2 knockdown was carefully examined. We observed that th  ...[more]

Similar Datasets

| S-EPMC2906576 | biostudies-literature
| S-EPMC6812687 | biostudies-literature
| S-EPMC2858285 | biostudies-literature
| S-EPMC10276834 | biostudies-literature
| S-EPMC4822373 | biostudies-literature
2023-05-07 | GSE167858 | GEO
| S-EPMC6348697 | biostudies-literature
| S-EPMC10931834 | biostudies-literature
| S-EPMC6279505 | biostudies-literature
| S-EPMC6851776 | biostudies-literature